While fibronectin pretreatment enhances growth suppression by stromal cells, deletion of fibronectin in a subpopulation of bone marrow cells counteracts the inhibition increasing cancer growth (Fig. 1G and 1K). The gene discussed is FN1; the disease is cancer.